|
 |
NolvadexThis page contains recent news articles, when available, and an overview of Nolvadex but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: Nolvadex (when available) Tamoxifen belongs to a class of drugs called selective estrogen receptor modulators (SERMs), which have both estrogenic and antiestrogenic effects. Tamoxifen has the same nucleus as diethylstilbestrol but possesses an additional side chain (trans isomer) which accounts for its antiestrogenic activity. Tamoxifen, chemically related to clomiphene., is used to in the therapy of metastatic breast cancer. for the treatment of breast cancer Mechanism Of Action: Tamoxifen binds to estrogen receptors (ER), inducing a conformational change in the receptor. This results in a blockage or change in the expression of estrogen dependent genes. The prolonged binding of tamoxifen to the nuclear chromatin of these results in reduced DNA polymerase activity, impaired thymidine utilization, blockade of estradiol uptake, and decreased estrogen response. It is likely that tamoxifen interacts with other coactivators or corepressors in the tissue and binds with different estrogen receptors, ER-alpha or ER-beta, producing both estrogenic and antiestrogenic effects. News Articles on Tamoxifen Health, Hope, Heroes: Rita's Story - Jul 11, 2008 My tumor was estrogen fed so I was fortunate that there was a NEW drug called Nolvadex aka Tamoxifen Citrate which had recently been distributed by the KCCI.com, Steroidy: NejdÅ™Ãv z vás udÄ›lajà frajera, pak vás zniÄ?à - Jul 23, 2008 Je jich celá Å™ada a majà mnoho názvů - namátkou tÅ™eba Dianabol, Oxandrolon, Nandrolon a Nolvadex. Majà napomoct růstu svalové hmoty, sÃly a agrese. Super.cz, Donne anziane: prevenzione delle fratture vertebrali con Evista - Jul 22, 2008 Il Raloxifene è efficace quanto il Tamoxifene ( Nolvadex ) nel ridurre il rischio di carcinoma invasivo alla mammella. Il principale problema di sicurezza XagenaSalute, Drugmakers Offer Aid To People 'on the Edge' - Jun 30, 2008 The drugmaker's first PAP, initiated in 1978, provided access to the breast cancer medicine Nolvadex. In the three decades since, the company has sponsored Washington Post, Hormone replacement therapy has its risks - Jun 27, 2008 Lobular breast cancer can be treated with hormone-based therapies, such as tamoxifen (Nolvadex), if caught early. Experts believe the incidence of lobular News 8 Austin, Oncotype DX® Also Provides Information About Breast Cancer Hormone ... - Jun 24, 2008 These therapies include tamoxifen [Nolvadex®] as well as agents known as aromatase inhibitors. Tamoxifen acts by blocking estrogen receptors, Cancer Consultants, Adjuvant Zometa® Improves Outcomes in Hormone-positive Breast ... - 02 Jun 2008 3) Nolvadex® (tamoxifen) plus Zometa; 4) Nolvadex alone. Treatment was continued for three years; the median follow-up of the trial was five years. Cancer Consultants, Addition of RAD001 to Femara® Improves Response to Breast Cancer ... - 02 Jun 2008 These therapies include tamoxifen [Nolvadex®] as well as agents known as aromatase inhibitors. Tamoxifen acts by blocking estrogen receptors, Cancer Consultants, Tamoxifen: 1001 uses of cancer drug extends to bipolar disorder - May 8, 2008 Tamoxifen - The breast cancer drug tamoxifen-marketed in the UK as Emblon, Noltam and Tamofen, and as Nolvadex in the US and the UK-has been enjoying some What Doctors Don't Tell You, Specific Gene Mutations May Affect Response to Tamoxifen in Breast ... - May 6, 2008 Mutations within the CYPD2 gene may affect the way in which a patient with hormone-positive breast cancer responds to tamoxifen (Nolvadex®). Cancer Consultants, From Mr Average ... to superman - May 17, 2008 A week's worth of double Nolvadex doses got the gyno under control. But by then my hair had started falling out. I have a scalp of unruly, bushman-like red The Observer, Deciding on breast cancer treatment: Tamoxifen versus aromatase ... - May 13, 2008 There are two main types of anti-estrogen medications: tamoxifen (Nolvadex), which blocks the ability of estrogen to stimulate cancer cell growth, Gather.com, Femara cuts cancer recurrence even if started late - 11 Mar 2008 But benefits of the pill, sold by AstraZeneca under the brand Nolvadex and also sold generically, fall significantly after five years. Reuters Clinical Oncology Publishes Findings from First-Ever Initiative on ... - 11 Mar 2008 AstraZeneca has provided the financial support for the five-year project and has donated (tamoxifen citrate) NOLVADEX and (anastrozole). ARIMIDEX. CSRwire.com (press release) Early Zometa® Prevents Bone Loss in Postmenopausal Women with ... - Mar 4, 2008 Femara is an aromatase inhibitior that is more effective than tamoxifen (Nolvadex®) in preventing recurrences in postmenopausal women with hormone Cancer Consultants, Ex-plastic surgeon killed wife, self, police say - Feb 15, 2008 ...drugs such as Nolvadex, Proscar, Clomid, Tamoxifen, Vicodin, Androgel, Ritalin and Viagra - "without accepted medical indication and/ or justification. Newsday, Risk Factors Identified for Uterine Sarcoma Survival - Feb 20, 2008 ...race, history of colorectal cancer, and use of the drug tamoxifen (Nolvadex®). This recent study evaluated results of the Surveillance, Epidemiology, Cancer Consultants, Certain Elderly Breast Cancer Patients More Likely to Die from ... - Feb 13, 2008 The hormone agent Femara® (letrozole) was compared to placebo (inactive substitute) following five years of treatment with tamoxifen (Nolvadex®) among Cancer Consultants, Targeted Therapies: A New Generation of Cancer Treatments - Mar 6, 2008 For decades, the use of the hormone receptor modulator tamoxifen (Nolvadex, brand no longer available in the United States) has been limited to the two RedOrbit, Fears of Recurrence Linked to Anxiety After DCIS Diagnosis - Feb 12, 2008 Among them, 34% reported having undergone mastectomy, 50% had received radiation therapy, and 43% took tamoxifen (Nolvadex). Nevertheless, a substantial MedPage Today, Conservative Surgery plus Tamoxifen May Be Safe in Elderly Breast ... - Jan 23, 2008 ...elderly women diagnosed with breast cancer may be effectively treated with conservative surgery followed by hormonal therapy with tamoxifen (Nolvadex®). Cancer Consultants (press release), Current Pharmaceutical Pipelines Are Testimony to the Intensity of ... - Jan 8, 2008 This increase counterbalances a drop in revenue from drugs such as Nolvadex(R), which have come off patent recently. In looking ahead, GlaxoSmithKline's Reuters Advances in Breast Cancer Treatment - Jan 25, 2008 ...in women treated with aromatase inhibitors, prediction of tamoxifen (Nolvadex®) response, and a newer and more convenient approach to radiation therapy. Cancer Consultants (press release), Reduced Long-term Risk of Contralateral Breast Cancer with ... - Jan 10, 2008 Patients treated with tamoxifen (Nolvadex®) had an approximately 34% lower risk of developing contralateral breast cancer than those who did not receive Cancer Consultants (press release), Control therapy side effects - Nov 16, 2007 Tamoxifen is sold under the trade name Nolvadex, and exemestane is sold under the trade name Aromasin. The patients had completed surgery and chemotherapy Health24.com, Lobbying Stalls Generic Drug Legislation - Nov 13, 2007 ...for several years, said she was amazed when she learned of the deal between Barr and astrazeneca, which sold tamoxifen under the brand name Nolvadex. The Associated Press The Ongoing Regulation of Generic Drugs - Nov 14, 2007 Such settlements occurred for K-Dur (potassium chloride), Cardizem (diltiazem), and Nolvadex (tamoxifen), among other drugs. These settlements have been New England Journal of Medicine (subscription), BUYINS.NET: (BRL) squeezetrigger Price is $54.300. There is ... - Oct 25, 2007 Tamoxifen is the generic name for astrazeneca's Nolvadex, which is used to treat advanced breast cancer, impede the recurrence of tumors following surgery, Trading Markets (press release), AIDS Drugs May Help Against Cancer, Too - Sep 17, 2007 Nelfinavir was also found to be effective against breast cancer cells that are resistant to currently used cancer drugs like Nolvadex (tamoxifen) and New York Times, BERICHT: Buy Drugs Without Prescription. No Prior Prescription ... - Oct 7, 2007 ...nizoral shampoo, medicine nizoral, taking testosterone gel with nolvadex, buying nolvadex legally, post cycle therapy nolvadex, aromasin nolvadex, Ermelo.org, AstraZeneca: No wholesale outsourcing - Sep 18, 2007 The Newark plant also packages Seroquel, Arimidex and Nolvadex, and seven other drugs including AstraZeneca's Crestor cholesterol-reducer. The News Journal, Evista - New Breast Cancer Drug - Sep 21, 2007 Tamoxifen® was the first such drug that was approved and has been marketed by Astra-Zeneca under the brand names Nolvadex®, Istubal®, and Valodex® and is InjuryBoard.com, Buy Drugs Without Prescription. Safe and Secure Ordering. - Oct 3, 2007 ...nizoral cream for skin, taking testosterone gel with nolvadex, nolvadex week, nolvadex sus, generic norvasc online, generic norvasc, norvasc alcohol, LIVE-Wintersport.com, Weekend Events Roundup, by An Adorable Kitten - Sep 21, 2007 Ever since I started on my 12-day cycle of Nolvadex, I’ve been feeling ornery! You know what else makes me feel ornery? When my kitty box is dirty! Pitch Weekly, Women Avoiding Cancer Pills Due To Side Effects - 07 Sep 2007 The pill under brand name Nolvadex sold by AstraZeneca and available generically, increases the death’s risk from strokes and endrometrial cancer. TopNews, Side effects force women off "safe" cancer pills - Sep 5, 2007 But the pill, sold by AstraZeneca under the brand name Nolvadex and also available generically, raises the risk of death from strokes and endometrial cancer Scientific American Breast Cancer Drug not Worth Side Effects for Some - Sep 6, 2007 Aromatase inhibitors are a recent addition to the breast cancer arsenal and are now being used in place of tamoxifen (Nolvadex), an older drug used to block WFIE-TV, Drug allegations against Tim Couch - Aug 28, 2007 The regimen also called for the use of Nolvadex, which suppresses estrogen levels, and Fluox, an antidepressant. Though Couch told Yahoo! Yahoo! Sports Hormones Not to Blame for Cancer in Mammographically Dense Breasts - Aug 21, 2007 ...exposure to estrogens based on evidence from hormone replacement therapy, tamoxifen (Nolvadex), and the role of endogenous hormones in breast cancer. MedPage Today, Anadrol-Oxymetholone – The Strongest Oral On The Market - Jul 25, 2007 PR-GB.com (press release),The most common anti-estrogen suggested is Nolvadex. Anadrol-Oxymetholone is a 17 alpha-alkylated compound. It is an oral drug with a dosage of 50mg per Aromatase Inhibitors Lead in Improved Survival with Metastatic ... - Jul 23, 2007 SeniorJournal.com,Another drug, tamoxifen (Nolvadex®), also helps to prevent the growth of estrogen-sensitive breast tumors, but it works differently from AIs. Lilly Wins Backing for Evista in Cancer Prevention (Update2) - Jul 24, 2007 BloombergSome women are reluctant to take tamoxifen, a generic drug first approved in 1977 as AstraZeneca Plc's Nolvadex, because of the potential for Brand Names/Synonyms: Nolvadex is also known by the following brand names and/or synonyms,Citrate; Apo-Tamox; CCRIS 3275; CTX; Citofen; Crisafeno; Diemon; Gen-Tamoxifen; HSDB 6782; Istubol; Kessar; Noltam; Nolvadex; Nolvadex-D; Nourytam; Novo-Tamoxifen; Oncomox; Pms-Tamoxifen; Retaxim; TRANS FORM OF TAMOXIFEN; Tamizam; Tamofen; Tamone; Tamoxasta; Tamoxen; Tamoxifen; Tamoxifen Citrate; Tamoxifen Drug Standard Solution; Tamoxifen and Its Salts; Tamoxifene [Inn-French]; Tamoxifeno [Inn-Spanish]; Tamoxifenum [Inn-Latin]; Trans-Tamoxifen; Valodex; Zemide Drug Category: Nolvadex is categorized under the following by the FDA: Antineoplastic Agents; ATC:L02BA01 Dosage Forms: TABLET Absorption: Not Available Interactions: -->Interactions for Tamoxifen: When NOLVADEX is used in combination with coumarin-type anticoagulants, a significant increase in anticoagulant effect may occur. Where such coadministration exists, careful monitoring of the patientís prothrombin time is recommended. In the NSABP P-1 trial, women who required coumarin-type anticoagulants for any reason were ineligible for participation in the trial. There is an increased risk of thromboembolic events occurring when cytotoxic agents are used in combination with NOLVADEX. Tamoxifen reduced letrozole plasma concentrations by 37%. The effect of tamoxifen on metabolism and excretion of other antineoplastic drugs, such as cyclophosphamide and other drugs that require mixed function oxidases for activation, is not known. Tamoxifen and N-desmethyl tamoxifen plasma concentrations have been shown to be reduced when coadministered with rifampin or aminoglutethimide. Induction of CYP3A4-mediated metabolism is considered to be the mechanism by which these reductions occur; other CYP3A4 inducing agents have not been studied to confirm this effect. One patient receiving NOLVADEX with concomitant phenobarbital exhibited a steady state serum level of tamoxifen lower than that observed for other patients (ie, 26 ng/mL vs. mean value of 122 ng/mL). However, the clinical significance of this finding is not known. Rifampin induced the metabolism of tamoxifen and significantly reduced the plasma concentrations of tamoxifen in 10 patients. Aminoglutethimide reduces tamoxifen and N desmethyl tamoxifen plasma concentrations. Medroxyprogesterone reduces plasma concentrations of N-desmethyl, but not tamoxifen. Concomitant bromocriptine therapy has been shown to elevate serum tamoxifen and N-desmethyl tamoxifen. Drug/Laboratory Testing Interactions: During postmarketing surveillance, T4 elevations were reported for a few postmenopausal patients which may be explained by increases in thyroid-binding globulin. These elevations were not accompanied by clinical hyperthyroidism. Variations in the karyopyknotic index on vaginal smears and various degrees of estrogen effect on Pap smears have been infrequently seen in postmenopausal patients given NOLVADEX. In the postmarketing experience with NOLVADEX, infrequent cases of hyperlipidemias have been reported. Periodic monitoring of plasma triglycerides and cholesterol may be indicated in patients with pre-existing hyperlipidemias . |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines mongabay.com
COPYRIGHT 2007 MONGABAY.COM |